JA
ANIK icon

JOYN Advisors’s Anika Therapeutics ANIK Stock Holding History

JOYN Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed – – 187
2018
Q4 		$0 Sell
3
-163
-98% -$5.88K ﹤0.01% 1743
2018
Q3 		$7K Buy
166
+103
+163% +$4.07K ﹤0.01% 1058
2018
Q2 		$2K Buy
63
+59
+1,475% +$2.43K ﹤0.01% 1377
2018
Q1 		$0 Buy
+4
New +$226 ﹤0.01% 1308

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JOYN Advisors's ANIK Position: Q1 2019 in Review

JOYN Advisors sold out of Anika Therapeutics (ANIK) in Q1 2019, closing a stake of 3 shares.

JOYN Advisors first reported a position in ANIK in Q1 2018 and held it in 4 quarters. The position peaked at $7K in Q3 2018. 157 funds tracked by Wall St. Rank hold ANIK as of Q1 2019.

  • JOYN Advisors reported no remaining Anika Therapeutics position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 3 Anika Therapeutics shares in Q1 2019.
  • JOYN Advisors first reported a position in Anika Therapeutics in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Anika Therapeutics position peaked at $7K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.